MTI University   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Cairo Egypt (2004)

Organization Overview

First Clinical Trial
2017
NCT03253562
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2024

Timeline

NOW
  • Now

Alternative names

Lecturer of pharmacology and toxicology | Marwa Elsayed | MTI University | MTI university, Egypt | MTI unuversity faculty of pharmacy

Active Ingredients

Drugs in Phase 4 Trials (3)

metformin (glucophage) (1 trial)

sofosbuvir (sovaldi) (2 trials)

vildagliptin (1 trial)

Drugs in Phase 1 Trials (1)

chitosan (1 trial)

Drugs in Other Trials (1)

bee venom (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 5